Examples of Infection Control Applications in a sentence
Company agrees to comply directly with the obligations set forth in the PHRI Agreement that arise as a result of the activities of Company and its Affiliates under this Agreement with respect to Infection Control Applications (including timely paying to Gen-Probe the royalties payable to PHRI or its successors or assigns under the PHRI Agreement in accordance with Section 3.1(b) of this Agreement).
If such officers are unable to resolve such issue within 30 days of commencing such negotiations, then the matter shall be submitted to an individual with expertise in the development of NATs for Infection Control Applications who is acceptable to both of the parties (the “Expert”), or if the parties are unable to agree upon the Expert, each party shall select its own individual who would qualify as an Expert and those two individuals shall select the Expert.
Gen-Probe reserves and retains all rights to the Gen-Probe Patents and Gen-Probe Know-How for all uses outside the Company Field, all rights to the Stanford Patents granted under the Stanford Agreement for all uses outside the Company Field, and all rights granted under the PHRI Agreement for all uses outside Infection Control Applications.
Gen-Probe and Company wish to amend the License Agreement to, among other things, clarify the nature of the Company’s rights with respect to Infection Control Applications (as such term is defined in the License Agreement).
For the avoidance of doubt, Company acknowledges that, with respect to Infection Control Applications, Gen-Probe shall have no obligation to provide Information about any organism other than MRSA, VREF and C.diff (including combinations thereof and, solely with respect to MRSA, in combination with Methicillin-sensitive Staphylococcus aureus) unless otherwise agreed to in writing by Gen-Probe.
Company may propose to Gen-Probe the joint development of NATs for commercialization by Gen-Probe on Panther and other instruments for one or more Infection Control Applications other than MRSA, VREF and C.diff.
The royalties payable by Company as provided under Sections 3.1(a) and (b) shall not exceed a maximum of [*] of aggregate annual Net Sales, except that such maximum shall instead be [*] of aggregate annual Net Sales of Products for Infection Control Applications.
The royalties payable by Company as provided under Sections 3.1(a) and (b) shall not exceed a maximum of 14.5% of aggregate annual Net Sales, except that such maximum shall instead be 16.0% of aggregate annual Net Sales of Products for Infection Control Applications.
Company may propose to Gen-Probe the joint development of NATs for commercialization by Gen-Probe on Panther and other instruments for one or more Infection Control Applications other than [*].
For the avoidance of doubt, Company acknowledges that, with respect to Infection Control Applications, Gen-Probe shall have no obligation to provide Information about any organism other than [*] unless otherwise agreed to in writing by Gen-Probe.